Global Flow
Cytometry Market is foretold to provide a
robust support for industry players to lay a solid foundation for their
business growth. It includes a comprehensive evaluation of the industry growth
status and risk. In addition, it provides detail market variables, trends, key
opportunities, new entrants & competitors.
Flow Cytometry Market study
offers detail overview of industry with all the requisite data to support
tactical business decisions and come up with strategic growth plans. This study
also proposes a comprehensive insight into the development policies and plans
in addition to manufacturing processes and cost structures.
Download Free Sample
Report Now @ https://www.millioninsights.com/industry-reports/flow-cytometry-market/request-sample
Industry Insights
The global flow cytometry
market size was estimated at USD 3.27 billion in 2016 and is anticipated to
grow at CAGR of 10.6% in coming years. Key drivers of this market include
increasing incidence of chronic disorders that requires toxicity testing for
cancer tests and need for quick, accurate and sensitive prognosis techniques
for the validation of disease.
Increasing awareness levels
amongst healthcare experts and patients coupled with rising healthcare
expenditures are major factors driving the growth. Furthermore, related
benefits of cell-based assays including development in reagents and software
employed for the study, ease-of-use and high sensitivity and reproductively are
some other elements anticipated to boost the growth in coming years.
Technology Insights
Cell-based technology held
the leading position in 2016. Rising demand for advance diagnosis and
increasing awareness related to related advantages with cell-based analysis are
the elements contributing to its leading position during the coming years.
Cell-based flow cytometry
involves substantial usage in variety of research fields. This analysis is
applied in the discovery of drug for physiological importance of results.
Furthermore, it is utilized in clinical studies involving endothelial cells in
blood, hematopoietic progenitor cells, and tumor cells in peripheral blood and
tumour stem cells. In addition, they are utilized in the study for target
identification and disease mechanism.
Application Insights
This technology is used in
industrial sectors, research and clinical diagnosis. Research segment held
leading position in 2016 due to increasing R&D for cancer and other
infectious diseases diagnosis and treatment. Flow cytometry has applications
even in some other industries including plant tissue culture and food
microbiology.
Clinical diagnosis is
anticipated to be the fastest growing application segment by the year 2025.
This growth is boosted by elements such as rising demand for cost-effective
disease diagnostic tools and related advantages of these assays in disease
detection.
End-use Insights
The commercial organization
segment dominated the industry due to extensive applications in various
verticals including plant cell culture, food microbiology and blood banks. The
entry of reagents and multiplex probes for definite usage in diagnostics and
discovery of drug is anticipated to benefit this vertical accompanied with
development opportunities by offering the users in research and small- scale
peripheral laboratories.
Hospitals are anticipated
to grow at remunerative CAGR owing to rising number of diagnostic tests
required by increasing prevalence of infectious and chronic diseases,
beneficial and supportive reimbursement policies and rising awareness among
patients.
Regional Insights
North America held leading
position in 2016 owing to the availability of solicitous government initiatives
for the growth of enhanced technologies pertaining to molecular diagnostics.
Furthermore, presence of skilled experts and larger awareness levels are the
other factors expected to drive the growth in regional market.
Asia Pacific is speculated
to demonstrate lucrative growth over the forecast period due to rising
solicitous government aid for the biotech industry growth. The economic
development, increasing patient awareness level, persistently advancing
healthcare infrastructure and presence of untapped opportunities are the
factors contributing towards the fast growth in this region.
Competitive Insights
Some major players
functioning in this industry include Agilent Technologies; Apogee Flow Systems
Ltd.; Becton, Dickinson and Company; Beckman Coulter, Inc.; Bio-Rad
Laboratories, Inc.; GE Healthcare; Luminex Corporation; Merck & Co., Inc.,
Miltenyi Biotec; Stratedigm, Inc.; Sysmex Corporation and Thermo Fisher
Scientific.
The market is fierce in
nature as major players are involved in persistent product development and
alliances to help market penetration. Rising number of outsourcing service
providers are anticipated to boost industry rivalry in the coming years.
Industry players are
acquiring product penetration by establishing manufacturing plants in the
untapped areas of developing countries. For instance, BD Life Sciences entered
into collaboration with Seegene Inc. in September 2015, for the advancement of
multiplex PCR reagents for BD max system in an inquest to attain more share.
Know
More Insights @ https://newsonmarketblog.wordpress.com
No comments:
Post a Comment